GGrantIndex
← Leaderboards

Isoplexis, Inc.

Wilmington, DE

Compare ↔
$18,897,114
Total funding
15
Grants

Funding over time

peak $4.5M · FY201521
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$18,897,114 · 15

By mechanism

R44$17,450,686 · 7
R43$1,446,428 · 8

Investigators at Isoplexis, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Largest grants

A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies$1,699,322
R44 · FY2019 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies$1,150,207
R44 · FY2020 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies$1,150,207
R44 · FY2021 · CA
A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases$999,615
R44 · FY2020 · AG
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance$999,016
R44 · FY2019 · CA
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation$996,470
R44 · FY2019 · CA
A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases$994,372
R44 · FY2021 · AG
A single-cell device to capture and analyze rare T-cells from solid tumors.$991,227
R44 · FY2017 · CA
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation$988,980
R44 · FY2020 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping$974,208
R44 · FY2017 · CA
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance$961,259
R44 · FY2020 · CA
A single-cell device to capture and analyze rare T-cells from solid tumors.$920,072
R44 · FY2018 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping$910,459
R44 · FY2018 · CA
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease$845,621
R44 · FY2018 · EB
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease$845,621
R44 · FY2017 · EB
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics$599,799
R44 · FY2017 · OD
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics$599,799
R44 · FY2018 · OD
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics$599,799
R44 · FY2019 · OD
Age-dependent Single-cell Metabolomic and Proteomic Profiling of Human Immune System$224,947
R43 · FY2019 · AG
A Combined High-Throughput Single-Cell Transcriptomic and Secretomic Assay for Neurodegenerative Disease Biomarker Discovery$224,895
R43 · FY2018 · NS